SwishX has launched an AI platform designed for pharmaceutical and medtech companies, focusing on sales, marketing, distribution and business operations.
The Bengaluru-based startup said the platform uses ‘Agentic AI’ technology to automate workflows and analyse large volumes of business and market data.
SwishX also announced that it has raised $2.2 million in seed funding from investors including Powerhouse Ventures, Blume Ventures, Sadev Ventures and Atrium Ventures.
The company is targeting $5 million in contracted annual recurring revenue and more than 100 enterprise clients by the end of the 2026-27 financial year. It also plans expansion into Latin America, Southeast Asia, the Middle East, Africa and Eastern Europe.
According to the company, India and other emerging markets together represent a $400 billion pharmaceutical and medtech opportunity, with the market expected to grow to $770 billion by 2033 at a compound annual growth rate of more than 12%.
The platform is aimed at addressing operational inefficiencies in the pharmaceutical sector, where many companies still rely on spreadsheets, disconnected software systems and manual processes for commercial decisions.
The platform can analyse government tenders, identify potential revenue leakages, assess product sales data and automate proposal creation. It also converts marketing documents into personalised video content for doctors.
The AI systems can analyse tender documents exceeding 500 pages and recommend pricing strategies within minutes.
Commenting on the launch, Dushyant Sapre, Founder & CEO, SwishX, said, “India’s pharma sector, recognized as the Pharmacy of the World, drives revenues of over USD 65 billion and Emerging Markets combined drive USD 400 billion while distributing into over 200 countries. Manufacturing and R&D have become genuinely world-class, but how these companies sell, market, and distribute, is still stuck in the past. Companies often struggle to know where losses are happening, what is selling, which tenders matter most, or how effectively teams are executing in the market. AI Agents change that completely. The next big transformation in this industry is not going to happen in the lab. It is going to happen in how these companies go to market. For the first time, companies can move to real-time autonomous execution.”
The platform has been built specifically for emerging markets, noting that India has more than 1.2 million pharmacies compared with about 100,000 in the United States, while a large share of procurement takes place through government tenders.
The launch comes as pharmaceutical companies globally increase AI adoption, with industry estimates suggesting AI could generate between $60 billion and $110 billion in annual value for the sector.